98 related articles for article (PubMed ID: 12525867)
21. Replication-defective genomic HSV gene therapy vectors: design, production and CNS applications.
Burton EA; Fink DJ; Glorioso JC
Curr Opin Mol Ther; 2005 Aug; 7(4):326-36. PubMed ID: 16121698
[TBL] [Abstract][Full Text] [Related]
22. Vesicular stomatitis virus glycoprotein: a transducing coat for SFV-based RNA vectors.
Dorange F; Piver E; Bru T; Collin C; Roingeard P; Pagès JC
J Gene Med; 2004 Sep; 6(9):1014-22. PubMed ID: 15352074
[TBL] [Abstract][Full Text] [Related]
23. Potential of herpesvirus saimiri-based vectors to reprogram a somatic Ewing's sarcoma family tumor cell line.
Brown HF; Unger C; Whitehouse A
J Virol; 2013 Jun; 87(12):7127-39. PubMed ID: 23596304
[TBL] [Abstract][Full Text] [Related]
24. Efficient lentiviral transduction of Herpesvirus saimiri immortalized T cells as a model for gene therapy in primary immunodeficiencies.
Toscano MG; Frecha C; Ortega C; Santamaría M; Martín F; Molina IJ
Gene Ther; 2004 Jun; 11(12):956-61. PubMed ID: 15029233
[TBL] [Abstract][Full Text] [Related]
25. Functional expression of thymidine kinase in human leukaemic and colorectal cells, delivered as EGFP fusion protein by herpesvirus saimiri-based vector.
Hoggarth JH; Jones E; Ensser A; Meredith DM
Cancer Gene Ther; 2004 Sep; 11(9):613-24. PubMed ID: 15243631
[TBL] [Abstract][Full Text] [Related]
26. Herpes simplex virus type 1 amplicon vectors for the infectious delivery and expression of genomic DNA loci.
Senior SL; Wade-Martins R
Curr Opin Mol Ther; 2005 Aug; 7(4):337-45. PubMed ID: 16121699
[TBL] [Abstract][Full Text] [Related]
27. Rhadinovirus vector-derived human telomerase reverse transcriptase expression in primary T cells.
Toptan T; Ensser A; Fickenscher H
Gene Ther; 2010 May; 17(5):653-61. PubMed ID: 20164858
[TBL] [Abstract][Full Text] [Related]
28. Quantitative comparison of polyethylenimine formulations and adenoviral vectors in terms of intracellular gene delivery processes.
Varga CM; Tedford NC; Thomas M; Klibanov AM; Griffith LG; Lauffenburger DA
Gene Ther; 2005 Jul; 12(13):1023-32. PubMed ID: 15815703
[TBL] [Abstract][Full Text] [Related]
29. Towards safe, non-viral therapeutic gene expression in humans.
Glover DJ; Lipps HJ; Jans DA
Nat Rev Genet; 2005 Apr; 6(4):299-310. PubMed ID: 15761468
[TBL] [Abstract][Full Text] [Related]
30. What can SV40-derived vectors do for gene therapy?
Strayer DS; Zern MA; Chowdhury JR
Curr Opin Mol Ther; 2002 Aug; 4(4):313-23. PubMed ID: 12222869
[TBL] [Abstract][Full Text] [Related]
31. Analysis of gene expression in a human cell line stably transduced with herpesvirus saimiri.
Hall KT; Giles MS; Goodwin DJ; Calderwood MA; Carr IM; Stevenson AJ; Markham AF; Whitehouse A
J Virol; 2000 Aug; 74(16):7331-7. PubMed ID: 10906186
[TBL] [Abstract][Full Text] [Related]
32. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.
Zhang J; Frolov I; Russell SJ
J Gene Med; 2004 Oct; 6(10):1082-91. PubMed ID: 15368589
[TBL] [Abstract][Full Text] [Related]
33. Genetic design of an optimized packaging cell line for gene vectors transducing human B cells.
Hettich E; Janz A; Zeidler R; Pich D; Hellebrand E; Weissflog B; Moosmann A; Hammerschmidt W
Gene Ther; 2006 May; 13(10):844-56. PubMed ID: 16421600
[TBL] [Abstract][Full Text] [Related]
34. Long-term retinal transgene expression with FIV versus adenoviral vectors.
Loewen N; Leske DA; Cameron JD; Chen Y; Whitwam T; Simari RD; Teo WL; Fautsch MP; Poeschla EM; Holmes JM
Mol Vis; 2004 Apr; 10():272-80. PubMed ID: 15094709
[TBL] [Abstract][Full Text] [Related]
35. Engineering cell lines for production of replication defective HSV-1 gene therapy vectors.
Grant KG; Krisky DM; Ataai MM; Glorioso JC
Biotechnol Bioeng; 2009 Mar; 102(4):1087-97. PubMed ID: 18828174
[TBL] [Abstract][Full Text] [Related]
36. PhiC31 integrase mediates integration in cultured synovial cells and enhances gene expression in rabbit joints.
Keravala A; Portlock JL; Nash JA; Vitrant DG; Robbins PD; Calos MP
J Gene Med; 2006 Aug; 8(8):1008-17. PubMed ID: 16779871
[TBL] [Abstract][Full Text] [Related]
37. Targeting HSV amplicon vectors.
Grandi P; Spear M; Breakefield XO; Wang S
Methods; 2004 Jun; 33(2):179-86. PubMed ID: 15121173
[TBL] [Abstract][Full Text] [Related]
38. Lentiviral vectors: are they the future of animal transgenesis?
Park F
Physiol Genomics; 2007 Oct; 31(2):159-73. PubMed ID: 17684037
[TBL] [Abstract][Full Text] [Related]
39. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
40. Stable transduction of large DNA by high-capacity adeno-associated virus/adenovirus hybrid vectors.
Gonçalves MA; van der Velde I; Knaän-Shanzer S; Valerio D; de Vries AA
Virology; 2004 Apr; 321(2):287-96. PubMed ID: 15051388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
